Результаты амбулаторной терапии иматинибом (гливек) в хронической фазе хронического миелолейкоза в зависимости от возраста и длительности предшествующей терапии

С. А. Волкова, Н. Н. Боровков, Е. А. Гостюжова et al. · Клиническая онкогематология. Фундаментальные исследования и клиническая практика · 2009

Analysis of effective out-patient therapy with imatinib (Glivec) in 100 patients in a chronic phase of chronic myeloid leukemia depending on the age of patients and duration of the previous treatment was made. 81 patients were younger than 60 years and 19 patients were elder than 60 years. The incidence of the cytogenetic, molecular responses and the overall, progress free and events free survival were estimated. Statistically relevant differences of Glivec therapy effectiveness depending on age of patients were not revealed. Out-patients treatment with Glivec for not more than 6 months previous treated patients showed the results similar to these within the research protocols.

Cited by 0 works.

Authors